Verition Fund Management
AGN

Verition Fund Management’s Allergan plc AGN Stock Holding History

Verition Fund Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,386,700
Closed -$246M – 1224
2020
Q1 		$246M Sell
1,386,700
-164,700
-11% -$31M 9.69% 1
2019
Q4 		$297M Buy
1,551,400
+166,700
+12% +$30.1M 5.4% 3
2019
Q3 		$232M Buy
1,384,700
+1,215,200
+717% +$198M 6.4% 1
2019
Q2 		$28.4M Buy
+169,500
New +$23.5M 0.8% 22

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Verition Fund Management's AGN Position: Q1 2020 in Review

Verition Fund Management sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 115,000 shares — an estimated $21.7M sold.

Verition Fund Management first reported a position in AGN in Q2 2013 and held it in 13 quarters. The position peaked at $23.6M in Q3 2019. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Verition Fund Management reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Verition Fund Management sold 115,000 Allergan plc shares in Q1 2020, an estimated $21.7M.
  • Verition Fund Management first reported a position in Allergan plc in Q2 2013 and held it in 13 quarters.
  • Verition Fund Management's Allergan plc position peaked at $23.6M in Q3 2019.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Verition Fund Management's 13F filing for Q1 2020, filed 15 May 2020.